Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphotherapy versus prednisolone for recurrent spontaneous abortion
IRCT20210115050041N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of prednisolone in recurrent miscarriage (RPL) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in natural killer T-cell percentage, Change in serum GM-CSF and 2 more. Started Apr 2021; status: completed.
02
Drugs
prednisolone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on IRCT20210115050041N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210115050041N2.